SLC6A2 and attention deficit-hyperactivity disorder: Hence, dysregulations of the plasma membrane monoamine transporters including DAT (dopamine transporter), NET (norepinephrine transporter) and SERT (serotonin transporter) have been implicated in a wide range of conditions such as depression, anxiety disorders, and attention-deficit hyperactivity disorder (ADHD) [1–4].